Skip to main content
. 2017 Aug 7;8(53):91150–91161. doi: 10.18632/oncotarget.20017

Table 7. Adverse events during IC in the two arms.

Adverse events TPF arm TP arm Z p
0 1 2 3 4 0 1 2 3 4
Hematologic
Leukocytopenia 1 4 19 29 4 8 22 31 10 4 –4.874 < 0.001
Neutropenia 1 6 8 20 22 14 15 29 12 5 –5.758 < 0.001
Anemia 39 14 3 1 0 51 15 7 2 0 –0.233 0.816
Thrombocytopenia 45 2 9 1 0 60 5 10 0 0 –0.278 0.781
Liver function 27 24 5 1 0 43 25 7 0 0 –1.066 0.286
Renal function 56 1 0 0 0 75 0 0 0 0 –1,147 0.251
Non-hematologic
Mucositis 40 10 5 2 0 68 5 2 0 0 –3.062 0.002
Dermatitis 52 5 0 0 0 69 6 0 0 0 –0.158 0.874
Diarrhea 38 15 3 1 0 70 3 2 0 0 –3.850 < 0.001
Nausea/vomiting 45 7 4 1 0 67 5 2 1 0 –1.644 0.100

Abbreviations: IC, induction chemotherapy.